Press Releases

Historic SomaLogic Press Releases >

Date	Title and Summary	Additional Formats
Apr 13, 2018	Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research Providing the industry’s first commercially available high-parameter immune monitoring solution for deep profiling of PBMC, Fluidigm brings proven mass cytometry together with innovative third-party data analysis SOUTH SAN FRANCISCO, Calif. , April 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation
Apr 12, 2018	Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System SOUTH SAN FRANCISCO, Calif. , April 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next-generation sequencing (NGS) library prep workflow for sequencing of the CFTR (cystic
Mar 13, 2018	Fluidigm Announces Exchange of Convertible Notes SOUTH SAN FRANCISCO, Calif. , March 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into separate privately negotiated transactions to exchange approximately $25.0 million in aggregate principal amount of its 2.75% Convertible Senior Notes due
Mar 02, 2018	Fluidigm Announces Exchange of Convertible Notes SOUTH SAN FRANCISCO, Calif. , March 02, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into separate privately negotiated transactions to exchange approximately $125.0 million in aggregate principal amount of its 2.75% Convertible Senior Notes due
May 16, 2016	Fluidigm Introduces Single-Cell TCR Sequencing on the C1 System at Immunology 2016™ SOUTH SAN FRANCISCO, Calif., May 16 2016 – Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of Single-Cell TCR Sequencing , a new immunology application on the C1™ system that enables in-depth profiling of T cells at single-cell resolution.
Nov 24, 2015	TIME Magazine Selects Fluidigm’s Juno system as One of the Best Inventions of 2015 Juno joins the Hoverboard Scooter, Tesla X and other inventions on this year’s prestigious list SOUTH SAN FRANCISCO, Calif., Nov. 24, 2015 – TIME Magazine has selected Fluidigm’s JunoTM system as one of the top 25 inventions of 2015. In its annual round-up of the best inventions that make the world
Oct 29, 2015	Fluidigm Reports Q3 2015 Financial Results SOUTH SAN FRANCISCO, Calif. – October 29, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2015. Total revenue for the third quarter of 2015 was $28.6 million, a decrease of 3% from $29.6 million in the third quarter of
Sep 04, 2015	Australia’s First Single-Cell Genomics Centre of Excellence Opens at Monash Health Translation Precinct Through an innovative and entrepreneurial approach to genomics medicine, the Centre intends to accelerate scientific discoveries. MELBOURNE, Australia and SOUTH SAN FRANCISCO, California, Sept. 4, 2015 – A partnership among Monash University, the University of Melbourne, the University of
Aug 25, 2015	High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1™ Now Every Laboratory can have Access to Large-Scale Surveys of Heterogeneity SOUTH SAN FRANCISCO, California, Aug. 25, 2015 – Fluidigm Corporation (NASDAQ: FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1™ system to enable
Aug 06, 2015	Fluidigm Reports Q2 2015 Financial Results SOUTH SAN FRANCISCO, Calif. – August 6, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June 30, 2015. Total revenue for the second quarter of 2015 was $28.6 million, an increase of 4% from $27.6 million in the second quarter of 2014.